David Peters

Vice President Corporate Development GLOBO

Warrington, Pennsylvania, United States

About

Growth oriented, strategic Senior Financial Executive and "Big 4" CPA with diverse experience. Deep experience working with Senior Executive teams and external Boards to deliver high growth, both organically and through acquisitions, while maintaining margins and profitability. Extensive international experience leading larger global organizations. Excellent team leader with a long track record of developing high performance Finance teams. Experience with public companies (including IPO), private companies and Private Equity. Led multiple exits with Private Equity Backed organizations resulting in significant returns including Bioclinica's sale to Cinven for $1.4B.

Experience

  • Vice Presdent Corporate Development at GLOBO
    Jan 2019 - Present · 7 yrs 6 mos

    GLOBO is a B2B provider of translation technology and services, giving organizations the ability to communicate in any language, 24/7 through one simple platform. GLOBO also offers real-time data, analytics and insights to help our users achieve greater understanding of their linguistically diverse customer bases. GLOBO’s full range of omni-channel services include on-demand telephone interpreting, video remote interpreting and email & chat translation, as well as project-based marketing transcreation, text translation, localization and on-site interpreting.

  • Board Member, Founder and Owner at G&C Group
    Dec 2011 - Present · 14 yrs 7 mos

    G&C Group is a retail services company founded in 2011. We currently have three retail locations in Southern New Jersey and over 50 employees.

  • Vice President Strategy and Strategic Advisor at Ancillare, LP
    Aug 2018 - Mar 2019 · 8 mos

    Ancillare is the market leader in Clinical Supply Chain Management for the clinical trials industry. Ancillare is the single point of contact for moving all the supplies required for a clinical trial and works in over 100 countries around the world. Responsibilities include strategic plans, M&A, partnership alliances with clients and assistance with financial planning and reporting.

  • Executive VP and Chief Financial Officer at BioClinica
    Jun 2015 - Feb 2018 · 2 yrs 9 mos

    BioClinica is a specialty clinical trials services provider that improves the development of new medical therapies by delivering expertise and technologies that enhance clinical research data and analytics, worldwide. The company offers industry-leading medical imaging services, enterprise eClinical technologies, clinical research centers and cardiovascular safety solutions that bring quality and efficiency to every phase of clinical development. BioClinica’s experience spans three decades andincludes thousands of studies in all therapeutic areas. The company serves more than 400 pharmaceutical, biotechnology, and device organizations – including all of the top 20 – through a network of offices in the U.S., Europe and Asia. Bioclinica is partnered with Cinven Partners, a premiere Private Equity firm based in London.

  • Chief Financial Officer at WCCT Global
    Jan 2014 - Jun 2015 · 1 yr 6 mos

    WCCT Global is a growth oriented CRO primarily focused on the Early Phase portion of the market and is partnered with Housatonics Partners a Private Equity firm. Responsibilities included the Finance and Accounting function, Strategic Growth initiatives, Acquisitions, HR, Contracts and reporting to the Board of Directors. Led a series B capital raise that partially exited existing shareholders as well as raising cash for growth initiatives and strategic investments.